A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.

Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a ...

HOUSTON – Retired former Houston Texans linebacker Bryan Braman, a popular special-teams ace known for his aggressive, ...

The 2025 CSAR Student Award winners were presented with their certificates by Dr Diarmuid O’Brien, the University of ...

The emergency room (ER) at a veterinary hospital is a place of urgency, heartbreak, hope, and, sometimes , miracles.  This ...

As Malaysia moves closer to becoming an aged nation by 2030, many adults over 60 are noticing leg discomfort, swelling and ...

Japanese researchers have developed artificial blood, potentially revolutionizing emergency medicine and addressing global blood shortages, particularly in countries like India. These lab-made red ...

Scientists in Austria are studying live human brain cells and comparing them to those of mice. Their findings raise new ...

We're delighted to announce $6.5 million in philanthropic investments from the Colonial Foundation and philanthropist, David Russell, to supercharge ...

NHS GP and ITV's Dr Amir Khan has shared a reason you may be getting colds and infections more regularly than normal, and ...